Yang-Ching Ko

448 total citations
9 papers, 401 citations indexed

About

Yang-Ching Ko is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yang-Ching Ko has authored 9 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yang-Ching Ko's work include Genomics, phytochemicals, and oxidative stress (4 papers), Synthesis and biological activity (2 papers) and Curcumin's Biomedical Applications (2 papers). Yang-Ching Ko is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Synthesis and biological activity (2 papers) and Curcumin's Biomedical Applications (2 papers). Yang-Ching Ko collaborates with scholars based in Taiwan. Yang-Ching Ko's co-authors include Jing‐Gung Chung, Jai‐Sing Yang, Shin‐Hwar Wu, Chi‐Cheng Lu, Tung-Yuan Lai, Liang-Wen Hang, Hung-Yi Chen, Jing-Pin Lin, Wu-Huei Hsu and Yi‐Ping Huang and has published in prestigious journals such as Molecules, Phytomedicine and Evidence-based Complementary and Alternative Medicine.

In The Last Decade

Yang-Ching Ko

9 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang-Ching Ko Taiwan 7 244 121 65 48 47 9 401
Laura Marzocchella Italy 11 248 1.0× 81 0.7× 38 0.6× 45 0.9× 40 0.9× 13 518
Chin-Chung Lin Taiwan 9 228 0.9× 83 0.7× 54 0.8× 27 0.6× 39 0.8× 9 356
Xiaofang Xu China 13 248 1.0× 54 0.4× 54 0.8× 56 1.2× 25 0.5× 29 466
Lu Jin China 15 315 1.3× 48 0.4× 75 1.2× 29 0.6× 29 0.6× 41 469
Bhornprom Yoysungnoen Thailand 10 249 1.0× 249 2.1× 40 0.6× 48 1.0× 30 0.6× 19 473
Su Taiwan 9 229 0.9× 77 0.6× 46 0.7× 30 0.6× 15 0.3× 38 401
Yung-Ting Hsiao Taiwan 14 244 1.0× 39 0.3× 70 1.1× 22 0.5× 31 0.7× 15 387
Abdulkader Hago United Arab Emirates 7 274 1.1× 139 1.1× 27 0.4× 25 0.5× 17 0.4× 10 384
Kuo-Ching Liu Taiwan 15 302 1.2× 51 0.4× 59 0.9× 37 0.8× 127 2.7× 16 588
Dalavaikodihalli Nanjaiah Nandakumar India 7 134 0.5× 69 0.6× 30 0.5× 19 0.4× 32 0.7× 7 350

Countries citing papers authored by Yang-Ching Ko

Since Specialization
Citations

This map shows the geographic impact of Yang-Ching Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang-Ching Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang-Ching Ko more than expected).

Fields of papers citing papers by Yang-Ching Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang-Ching Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang-Ching Ko. The network helps show where Yang-Ching Ko may publish in the future.

Co-authorship network of co-authors of Yang-Ching Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Yang-Ching Ko. A scholar is included among the top collaborators of Yang-Ching Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang-Ching Ko. Yang-Ching Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lien, Jin‐Cherng, Yi‐Ping Huang, Ching-Lung Liao, et al.. (2016). Casticin Inhibits A375.S2 Human Melanoma Cell Migration/Invasion through Downregulating NF-κB and Matrix Metalloproteinase-2 and -1. Molecules. 21(3). 384–384. 20 indexed citations
2.
Ko, Yang-Ching, Jin‐Cherng Lien, Shu‐Chun Hsu, et al.. (2015). Demethoxycurcumin induces the apoptosis of human lung cancer NCI-H460 cells through the mitochondrial-dependent pathway. Oncology Reports. 33(5). 2429–2437. 27 indexed citations
3.
Ko, Yang-Ching, et al.. (2015). Demethoxycurcumin alters gene expression associated with DNA damage, cell cycle and apoptosis in human lung cancer NCI-H460 cells in vitro.. PubMed. 29(1). 83–94. 5 indexed citations
4.
Huang, Yi‐Ping, Chi‐Cheng Lu, Jo‐Hua Chiang, et al.. (2013). Suppressions of Migration and Invasion by Cantharidin in TSGH-8301 Human Bladder Carcinoma Cells through the Inhibitions of Matrix Metalloproteinase-2/-9 Signaling. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 30 indexed citations
5.
Wu, Ping-Ping, Kuo-Ching Liu, Wen-Wen Huang, et al.. (2011). Diallyl trisulfide (DATS) inhibits mouse colon tumor in mouse CT-26 cells allograft model in vivo. Phytomedicine. 18(8-9). 672–676. 41 indexed citations
6.
Tang, Nou-Ying, Yating Huang, Yang-Ching Ko, et al.. (2011). Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.. PubMed. 31(5). 1691–702. 40 indexed citations
7.
Ko, Yang-Ching, et al.. (2010). Proteomic analysis of CD4+ T-lymphocytes in patients with asthma between typical therapy (controlled) and no typical therapy (uncontrolled) level. Human & Experimental Toxicology. 30(7). 541–549. 4 indexed citations
8.
Wu, Shin‐Hwar, Liang-Wen Hang, Jai‐Sing Yang, et al.. (2010). Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.. PubMed. 30(6). 2125–33. 222 indexed citations
9.
Ko, Yang-Ching, et al.. (2009). Serum and Pleural Fluid Procalcitonin in Predicting Bacterial Infection in Patients with Parapneumonic Effusion. Journal of Korean Medical Science. 24(3). 398–398. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026